HCA Quantitative Stock Analysis

HCA Healthcare Inc. (HCA) received an 87% rating from Validea's Multi-Factor Investor model, based on Pim van Vliet's strategy which targets low volatility stocks with strong momentum and high net payout yields. This score indicates "some interest" in the large-cap healthcare facility stock, which passed criteria for market capitalization and standard deviation but was neutral on momentum and net payout yield, ultimately failing the overall final rank according to the model's assessment.

Analysis

HCA Healthcare Inc. (HCA) presents a mixed profile according to Validea's multi-factor model based on Pim van Vliet's conservative investment strategy. While the stock achieves a high preliminary rating of 87%, indicating some interest, it ultimately receives a "FAIL" on the model's final rank. The analysis reveals HCA successfully meets the criteria for a large-cap, low-volatility stock, passing both the market capitalization and standard deviation tests. However, it demonstrates weakness in the other core pillars of the strategy, scoring only "NEUTRAL" on both "Twelve Minus One Momentum" and "Net Payout Yield". This discrepancy suggests that while HCA possesses the desired defensive characteristics of a low-risk asset, it currently lacks the strong performance momentum and high shareholder return (via dividends and buybacks) that the model requires for a full endorsement. The overall assessment is therefore one of a conservative stock that does not meet the specific return-enhancing criteria of this particular quantitative screen.

Key Decisions for Investors

• Investors prioritizing capital preservation and low volatility may find HCA's profile appealing given its 'PASS' on the standard deviation criterion, but should note its current deficiency in momentum and yield.
• Strict followers of quantitative, multi-factor strategies like Pim van Vliet's should interpret the 'FAIL' on the Final Rank as a clear signal to avoid or underweight the stock until its momentum and yield metrics improve.
• Portfolio managers should monitor HCA's net payout yield and momentum indicators, as a positive shift in these 'NEUTRAL' factors could trigger a buy signal from similar quantitative models, potentially driving future inflows.